LivaNova PLC Income Tax Expense
LivaNova PLC (LIVN) reported Income Tax Expense of -$90.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-05
- LivaNova PLC income tax expense (benefit) for the quarter ending 2026-06-30 was -$90.20M, a 1566.49% decline year-over-year.
- LivaNova PLC income tax expense (benefit) for the quarter ending 2026-03-31 was $4.34M, a 62.77% decline year-over-year.
- LivaNova PLC income tax expense (benefit) for the quarter ending 2025-12-31 was -$3.28M, a 657.22% decline year-over-year.
- LivaNova PLC income tax expense (benefit) for the quarter ending 2025-09-30 was $7.11M, a 38.27% decline year-over-year.
- LivaNova PLC income tax expense (benefit) for fiscal 2025 was $21.64M, a 13.64% decline from fiscal 2024.
- LivaNova PLC income tax expense (benefit) for fiscal 2024 was $25.06M.
- LivaNova PLC income tax expense (benefit) for fiscal 2023 was -$98.88M, a 994.72% decline from fiscal 2022.
- LivaNova PLC income tax expense (benefit) for fiscal 2022 was $11.05M, a 1.31% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 7 month | Income Tax Expense (Benefit) 8 month | Income Tax Expense (Benefit) 8 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$90.20M 10-Q · filed 2026-08-05 | -$85.86M 10-Q · filed 2026-08-05 | -$89.15M derived: sum of 3 quarters · filed 2026-08-05 | -$82.03M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2026-03-31 | $4.34M 10-Q · filed 2026-05-06 | $1.06M derived: sum of 2 quarters · filed 2026-05-06 | $8.17M derived: sum of 3 quarters · filed 2026-05-06 | $14.32M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2025-12-31 | -$3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.83M derived: sum of 2 quarters · filed 2026-02-25 | $9.98M derived: sum of 3 quarters · filed 2026-08-05 | $21.64M 10-K · filed 2026-02-25 | |||||||
| 2025-09-30 | $7.11M 10-Q · filed 2025-11-05 | $13.27M derived: sum of 2 quarters · filed 2026-08-05 | $24.92M 10-Q · filed 2025-11-05 | $25.51M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2025-06-30 | $6.15M 10-Q · filed 2026-08-05 | $17.81M 10-Q · filed 2026-08-05 | $18.40M derived: sum of 3 quarters · filed 2026-08-05 | $29.92M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2025-03-31 | $11.66M 10-Q · filed 2026-05-06 | $12.24M derived: sum of 2 quarters · filed 2026-05-06 | $23.77M derived: sum of 3 quarters · filed 2026-05-06 | $29.00M derived: sum of 4 quarters · filed 2026-05-06 | |||||||
| 2024-12-31 | $589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.11M derived: sum of 2 quarters · filed 2026-02-25 | $17.34M derived: sum of 3 quarters · filed 2026-02-25 | $25.06M 10-K · filed 2026-02-25 | |||||||
| 2024-09-30 | $11.53M 10-Q · filed 2025-11-05 | $16.75M derived: sum of 2 quarters · filed 2025-11-05 | $24.47M 10-Q · filed 2025-11-05 | -$86.18M derived: sum of 4 quarters · filed 2026-02-25 | |||||||
| 2024-06-30 | $5.23M 10-Q · filed 2025-08-06 | $12.94M 10-Q · filed 2025-08-06 | -$97.71M derived: sum of 3 quarters · filed 2026-02-25 | -$92.40M derived: sum of 4 quarters · filed 2026-02-25 | |||||||
| 2024-03-31 | $7.72M 10-Q · filed 2025-05-07 | -$102.94M derived: sum of 2 quarters · filed 2026-02-25 | -$97.63M derived: sum of 3 quarters · filed 2026-02-25 | -$93.53M derived: sum of 4 quarters · filed 2026-02-25 | |||||||
| 2023-12-31 | -$110.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$105.34M derived: sum of 2 quarters · filed 2026-02-25 | -$101.25M derived: sum of 3 quarters · filed 2026-02-25 | -$98.88M 10-K · filed 2026-02-25 | |||||||
| 2023-09-30 | $5.31M 10-Q · filed 2024-10-31 | $9.40M derived: sum of 2 quarters · filed 2024-10-31 | $11.78M 10-Q · filed 2024-10-31 | $16.48M derived: sum of 4 quarters · filed 2025-02-25 | |||||||
| 2023-06-30 | $4.10M 10-Q · filed 2024-08-01 | $6.47M 10-Q · filed 2024-08-01 | $11.17M derived: sum of 3 quarters · filed 2025-02-25 | $12.47M derived: sum of 4 quarters · filed 2025-02-25 | |||||||
| 2023-03-31 | $2.37M 10-Q · filed 2024-05-03 | $7.08M derived: sum of 2 quarters · filed 2025-02-25 | $8.37M derived: sum of 3 quarters · filed 2025-02-25 | $10.88M derived: sum of 4 quarters · filed 2025-02-25 | |||||||
| 2022-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $6.00M derived: sum of 2 quarters · filed 2025-02-25 | $8.51M derived: sum of 3 quarters · filed 2025-02-25 | $11.05M 10-K · filed 2025-02-25 | |||||||
| 2022-09-30 | $1.29M 10-Q · filed 2023-11-01 | $3.81M derived: sum of 2 quarters · filed 2023-11-01 | $6.35M 10-Q · filed 2023-11-01 | $9.13M derived: sum of 4 quarters · filed 2024-02-29 | |||||||
| 2022-06-30 | $2.52M 10-Q · filed 2023-07-26 | $5.05M 10-Q · filed 2023-07-26 | $7.84M derived: sum of 3 quarters · filed 2024-02-29 | $9.70M derived: sum of 4 quarters · filed 2024-02-29 | |||||||
| 2022-03-31 | $2.54M 10-Q · filed 2023-05-03 | $5.33M derived: sum of 2 quarters · filed 2024-02-29 | $7.18M derived: sum of 3 quarters · filed 2024-02-29 | $11.09M derived: sum of 4 quarters · filed 2024-02-29 | |||||||
| 2021-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $4.65M derived: sum of 2 quarters · filed 2024-02-29 | $8.55M derived: sum of 3 quarters · filed 2024-02-29 | $11.20M 10-K · filed 2024-02-29 | |||||||
| 2021-09-30 | $1.86M 10-Q · filed 2022-11-02 | $2.10M 10-Q · filed 2021-11-03 | $5.77M derived: sum of 2 quarters · filed 2022-11-02 | $8.41M 10-Q · filed 2022-11-02 | $9.09M 10-Q · filed 2021-11-03 | -$10.13M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2021-06-30 | $3.91M 10-Q · filed 2022-08-03 | $4.14M 10-Q · filed 2021-07-28 | $6.55M 10-Q · filed 2022-08-03 | $7.00M 10-Q · filed 2021-07-28 | -$11.99M derived: sum of 3 quarters · filed 2023-02-27 | -$15.98M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2021-03-31 | $2.64M 10-Q · filed 2022-05-04 | $2.86M 10-Q · filed 2021-04-28 | -$15.90M derived: sum of 2 quarters · filed 2023-02-27 | -$19.89M derived: sum of 3 quarters · filed 2023-02-27 | $46.40M derived: sum of 4 quarters · filed 2023-02-27 | ||||||
| 2020-12-31 | -$18.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$22.53M derived: sum of 2 quarters · filed 2023-02-27 | $43.75M derived: sum of 3 quarters · filed 2023-02-27 | -$960.00K 10-K · filed 2023-02-27 | -$736.00K 10-K · filed 2021-03-01 | ||||||
| 2020-09-30 | -$3.99M 10-Q · filed 2021-11-03 | $62.30M derived: sum of 2 quarters · filed 2021-11-03 | $17.58M 10-Q · filed 2021-11-03 | $10.64M derived: sum of 4 quarters · filed 2022-03-01 | |||||||
| 2020-06-30 | $66.28M 10-Q · filed 2021-07-28 | $21.57M 10-Q · filed 2021-07-28 | $14.63M derived: sum of 3 quarters · filed 2022-03-01 | $3.98M derived: sum of 4 quarters · filed 2022-03-01 | |||||||
| 2020-03-31 | -$44.71M 10-Q · filed 2021-04-28 | -$51.66M derived: sum of 2 quarters · filed 2022-03-01 | -$62.31M derived: sum of 3 quarters · filed 2022-03-01 | -$68.47M derived: sum of 4 quarters · filed 2022-03-01 | |||||||
| 2019-12-31 | -$6.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$17.60M derived: sum of 2 quarters · filed 2022-03-01 | -$23.76M derived: sum of 3 quarters · filed 2022-03-01 | -$30.37M 10-K · filed 2022-03-01 | -$30.15M 10-K · filed 2020-03-02 | ||||||
| 2019-09-30 | -$10.65M 10-Q · filed 2020-10-29 | -$16.82M derived: sum of 2 quarters · filed 2020-10-29 | -$23.43M 10-Q · filed 2020-10-29 | -$93.26M derived: sum of 4 quarters · filed 2021-03-01 | |||||||
| 2019-06-30 | -$6.16M 10-Q · filed 2020-07-29 | -$12.78M 10-Q · filed 2020-07-29 | -$82.61M derived: sum of 3 quarters · filed 2021-03-01 | -$85.27M derived: sum of 4 quarters · filed 2021-03-01 | |||||||
| 2019-03-31 | -$6.61M 10-Q · filed 2020-04-30 | -$76.45M derived: sum of 2 quarters · filed 2021-03-01 | -$79.11M derived: sum of 3 quarters · filed 2021-03-01 | -$80.14M derived: sum of 4 quarters · filed 2021-03-01 | |||||||
| 2018-12-31 | -$69.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$72.49M derived: sum of 2 quarters · filed 2021-03-01 | -$73.52M derived: sum of 3 quarters · filed 2021-03-01 | -$69.63M 10-K · filed 2021-03-01 | |||||||
| 2018-09-30 | -$2.66M 10-Q · filed 2019-10-30 | -$3.69M derived: sum of 2 quarters · filed 2019-10-30 | $203.00K 10-Q · filed 2019-10-30 | $39.34M derived: sum of 4 quarters · filed 2020-03-02 | |||||||
| 2018-06-30 | -$1.03M 10-Q · filed 2019-07-31 | $2.86M 10-Q · filed 2019-07-31 | $42.00M derived: sum of 3 quarters · filed 2020-03-02 | $43.90M derived: sum of 4 quarters · filed 2020-03-02 | |||||||
| 2018-03-31 | $3.89M 10-Q · filed 2019-05-01 | $43.03M derived: sum of 2 quarters · filed 2020-03-02 | $44.93M derived: sum of 3 quarters · filed 2020-03-02 | $48.19M derived: sum of 4 quarters · filed 2020-03-02 | |||||||
| 2017-12-31 | $39.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $41.04M derived: sum of 2 quarters · filed 2020-03-02 | $44.30M derived: sum of 3 quarters · filed 2020-03-02 | $49.95M 10-K · filed 2020-03-02 | |||||||
| 2017-09-30 | $1.91M 10-Q · filed 2018-11-01 | $1.91M 10-Q · filed 2017-11-02 | $5.16M derived: sum of 2 quarters · filed 2018-11-01 | $10.82M 10-Q · filed 2018-11-01 | $10.88M 10-Q · filed 2017-11-02 | -$959.00K derived: sum of 4 quarters · filed 2019-03-18 | |||||
| 2017-06-30 | $3.26M 10-Q · filed 2018-08-02 | $3.31M 10-Q · filed 2017-08-09 | $8.91M 10-Q · filed 2018-08-02 | $8.97M 10-Q · filed 2017-08-09 | -$2.86M derived: sum of 3 quarters · filed 2019-03-18 | $6.87M derived: sum of 4 quarters · filed 2019-03-18 | |||||
| 2017-03-31 | $5.66M 10-Q · filed 2018-05-03 | -$6.12M derived: sum of 2 quarters · filed 2019-03-18 | $3.61M derived: sum of 3 quarters · filed 2019-03-18 | $12.03M derived: sum of 4 quarters · filed 2019-03-18 | |||||||
| 2016-12-31 | -$11.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$2.05M derived: sum of 2 quarters · filed 2019-03-18 | $6.37M derived: sum of 3 quarters · filed 2019-03-18 | $5.11M 10-K · filed 2019-03-18 | $7.13M 10-K · filed 2017-03-01 | ||||||
| 2016-09-30 | $9.73M 10-Q · filed 2017-11-02 | $18.15M derived: sum of 2 quarters · filed 2017-11-02 | $16.89M 10-Q · filed 2017-11-02 | ||||||||
| 2016-06-30 | $8.42M 10-Q · filed 2017-08-09 | $7.16M 10-Q · filed 2017-08-09 | |||||||||
| 2016-03-31 | -$1.26M 10-Q · filed 2017-05-03 | ||||||||||
| 2015-12-31 | -$13.50M 10-K · filed 2018-02-28 | -$12.98M 10-KT · filed 2016-03-04 | |||||||||
| 2015-10-18 | -$1.46M 10-Q · filed 2016-11-02 | -$1.46M 10-Q · filed 2015-12-02 | $5.34M 10-Q · filed 2015-12-08 | $11.69M 10-Q · filed 2016-11-02 | |||||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | |||||||||
| 2015-07-24 | $6.80M 10-Q · filed 2016-08-05 | $13.15M 10-Q · filed 2016-08-05 | |||||||||
| 2015-04-24 | $6.35M 10-Q · filed 2016-05-09 | $31.45M 10-K · filed 2018-02-28 | |||||||||
| 2014-12-26 | $18.79M 10-K · filed 2018-02-28 | ||||||||||
| 2014-10-24 | $9.02M 10-Q · filed 2015-12-08 | $17.72M 10-Q · filed 2015-12-08 | |||||||||
| 2014-04-25 | $24.99M 10-K · filed 2017-03-01 | ||||||||||
| 2013-04-26 | $28.92M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |